Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000865938 | SCV000319345 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705391 | SCV000730559 | likely benign | not provided | 2021-05-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000865938 | SCV001006968 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000865938 | SCV001333309 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-02-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955401 | SCV004775792 | likely benign | TGFBR1-related condition | 2021-09-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |